These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8101879)

  • 1. Biologically active conformers of phenothiazines and thioxanthenes. Further evidence for a ligand model of dopamine D2 receptor antagonists.
    Froimowitz M; Cody V
    J Med Chem; 1993 Jul; 36(15):2219-27. PubMed ID: 8101879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incorporation of butyrophenones and related compounds into a pharmacophore for dopamine D2 antagonists.
    Froimowitz M; Cody V
    Drug Des Discov; 1997 Aug; 15(2):63-81. PubMed ID: 9342550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational properties of semirigid antipsychotic drugs: the pharmacophore for dopamine D-2 antagonist activity.
    Froimowitz M; Rämsby S
    J Med Chem; 1991 May; 34(5):1707-14. PubMed ID: 1674541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible interaction of beta-haloalkylamine derivatives with dopamine D1 and D2 receptors.
    Cross AJ; Waddington JL; Ross ST
    Life Sci; 1983 Jun; 32(24):2733-40. PubMed ID: 6222234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor pharmacology. Its use in neuroleptic research.
    Hyttel J
    Acta Psychiatr Belg; 1987; 87(5):535-51. PubMed ID: 2897759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibacterial effect of selected phenothiazines and thioxanthenes on slow-growing mycobacteria.
    Kristiansen JE; Vergmann B
    Acta Pathol Microbiol Immunol Scand B; 1986 Dec; 94(6):393-8. PubMed ID: 3105243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacophore model for dopamine D4 receptor antagonists.
    Boström J; Gundertofte K; Liljeforsa T
    J Comput Aided Mol Des; 2000 Nov; 14(8):769-86. PubMed ID: 11131969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 5-HT1A and dopamine D2 pharmacophores. X-ray structures and affinities of conformationally constrained ligands.
    Chidester CG; Lin CH; Lahti RA; Haadsma-Svensson SR; Smith MW
    J Med Chem; 1993 May; 36(10):1301-15. PubMed ID: 8496900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile.
    Stefanowicz J; Słowiński T; Wróbel MZ; Herold F; Gomółka AE; Wesołowska A; Jastrzębska-Więsek M; Partyka A; Andres-Mach M; Czuczwar SJ; Łuszczki JJ; Zagaja M; Siwek A; Nowak G; Żołnierek M; Bączek T; Ulenberg S; Belka M; Turło J
    Bioorg Med Chem; 2016 Sep; 24(18):3994-4007. PubMed ID: 27377863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics.
    Kaczor AA; Silva AG; Loza MI; Kolb P; Castro M; Poso A
    ChemMedChem; 2016 Apr; 11(7):718-29. PubMed ID: 26990027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indoles. 10. Synthesis, structure and D2-affinity of beta-carboline analogs of flutroline].
    Lehmann J; Knoch F; Jiang N
    Arch Pharm (Weinheim); 1993 Dec; 326(12):947-51. PubMed ID: 7907210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity.
    Bøgesø KP; Arnt J; Frederiksen K; Hansen HO; Hyttel J; Pedersen H
    J Med Chem; 1995 Oct; 38(22):4380-92. PubMed ID: 7473566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent haloperidol derivatives covalently binding to the dopamine D2 receptor.
    Schwalbe T; Kaindl J; Hübner H; Gmeiner P
    Bioorg Med Chem; 2017 Oct; 25(19):5084-5094. PubMed ID: 28666858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of butyrylcholinesterase by phenothiazine derivatives.
    Debord J; Merle L; Bollinger JC; Dantoine T
    J Enzyme Inhib Med Chem; 2002 Jun; 17(3):197-202. PubMed ID: 12443046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Induction of hepatic tyrosine transaminase in rats by phenothiazine derivatives and analogs].
    Amory C; Mainard F; Bousquet B
    C R Acad Hebd Seances Acad Sci D; 1978 Jul; 287(2):97-100. PubMed ID: 29715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical, pharmacological, and metabolic considerations on thiothixene. Introduction: chemical and pharmacological relationship of thioxanthenes and phenothiazines.
    Weissman A
    Adv Biochem Psychopharmacol; 1974; 9(0):471-80. PubMed ID: 4151768
    [No Abstract]   [Full Text] [Related]  

  • 18. Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands.
    Charifson PS; Bowen JP; Wyrick SD; Hoffman AJ; Cory M; McPhail AT; Mailman RB
    J Med Chem; 1989 Sep; 32(9):2050-8. PubMed ID: 2527994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.
    Wilson JM; Sanyal S; Van Tol HH
    Eur J Pharmacol; 1998 Jun; 351(3):273-86. PubMed ID: 9721018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optically active benzamides as predictive tools for mapping the dopamine D2 receptor.
    Rognan D; Sokoloff P; Mann A; Martres MP; Schwartz JC; Costentin J; Wermuth CG
    Eur J Pharmacol; 1990 Jul; 189(1):59-70. PubMed ID: 1977603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.